Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Non-Current Deffered Revenue: 2013-2016

Historic Non-Current Deffered Revenue for Tvardi Therapeutics (TVRD) over the last 4 years, with Dec 2016 value amounting to $1.6 million.

  • Tvardi Therapeutics' Non-Current Deffered Revenue rose 11.54% to $1.7 million in Q3 2017 from the same period last year, while for Sep 2017 it was $1.7 million, marking a year-over-year increase of 11.54%. This contributed to the annual value of $1.6 million for FY2016, which is 168.38% up from last year.
  • According to the latest figures from FY2016, Tvardi Therapeutics' Non-Current Deffered Revenue is $1.6 million, which was up 168.38% from $585,000 recorded in FY2015.
  • In the past 5 years, Tvardi Therapeutics' Non-Current Deffered Revenue registered a high of $1.6 million during FY2016, and its lowest value of $585,000 during FY2015.
  • In the last 3 years, Tvardi Therapeutics' Non-Current Deffered Revenue had a median value of $874,000 in 2014 and averaged $1.0 million.
  • In the last 5 years, Tvardi Therapeutics' Non-Current Deffered Revenue crashed by 33.07% in 2015 and then spiked by 168.38% in 2016.
  • Tvardi Therapeutics' Non-Current Deffered Revenue (Yearly) stood at $1.1 million in 2013, then decreased by 23.27% to $874,000 in 2014, then plummeted by 33.07% to $585,000 in 2015, then spiked by 168.38% to $1.6 million in 2016.